Published • loading... • Updated
Carvolix Receives Financing to Accelerate Commercialization of TAVIpilot Software
Summary by Cardiac Interventions Today
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.1 Articles
1 Articles
Carvolix Receives Financing to Accelerate Commercialization of TAVIpilot Software
August 18, 2026—Claret Capital Partners announced it has made an investment of €30 million in Carvolix. Claret Capital is a European, independent, growth debt fund manager. Carvolix was founded by Truffle Capital and formerly known as Affluent Medical, which acquired Caranx Medical and Artedrone in January 2026. Based in Aix-en-Provence, France, Carvolix is a commercial- and clinical-stage medical technology company specializing in the developme…
Coverage Details
Total News Sources1
Leaning Left0Leaning Right0Center0Last UpdatedBias DistributionNo sources with tracked biases.
Bias Distribution
- There is no tracked Bias information for the sources covering this story.
Factuality
To view factuality data please Upgrade to Premium
